Patient Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001854794

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Samantha McLemore — tracked via quarterly SEC 13F filings · All famous investors

MidHigh Turnover how tags are computed

Q4 2025 · 40 positions · Total reported value $2.59B · Top-10 concentration 49.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 69.0% · 3 new · 23 cut · 3 exited

Active Share (vs S&P 500): 80.6% · vs QQQ: 81.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +3.9% · vs SPY +1.8% · Prev Value $2.99B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.4% · vs SPY -2.6% · Latest Value $2.96B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Patient Capital Management, LLC disclosed 40 equity positions with a combined reported value of $2.59B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 49.2% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q4 2025 were GOOGL ($182.05M), C ($150.74M), AMZN ($129.85M). By sector, the heaviest allocations are Consumer Discretionary 29.3%, Health Care 19.5%. Versus the prior quarter, allocation shifted toward Health Care (+2.1pp), Other (+0.8pp) and away from Consumer Discretionary (-2.9pp).

Versus the prior quarter, Patient Capital Management, LLC opened 3 new positions, trimmed 23 and fully exited 3, a turnover rate of 69.0% of positions. The portfolio's overlap with the prior quarter was 88% of names.

The largest new positions opened in Q4 2025 were CHYM ($51.22M), FISV ($17.41M).

Of the 3 positions fully exited versus the prior quarter, the largest were ANGI ($13.00M), KOS ($5.50M), MSTR ($674.40K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • CHYM CHIME FINL INC · $51.22M
  • FISV FISERV INC · $17.41M

Fully Exited (vs previous quarter)

  • ANGI ANGI INC · prev qtr: $13.00M
  • KOS KOSMOS ENERGY LTD · prev qtr: $5.50M
  • MSTR STRATEGY INC · prev qtr: $674.40K

Insider Transactions (Form 4)

Latest Samantha McLemore buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Patient Capital Management, LLC is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 39 US equity positions with a combined value of $2.99B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-118170 (status: Approved), registered 2020-03-05
  • Regulatory AUM (Form ADV): $2.50B as of 2026-03-27
  • Client mix (by RAUM): registered investment companies 85%, pension and profit-sharing plans 9%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: patientcapitalmanagement.com

Portfolio Structure

  • 39 positions · $2.99B reported value (Q2 2026)
  • Top 10 holdings = 52.4% of reported value
  • Largest position: RPRX (ROYALTY PHARMA PLC) at 6.8%
  • Average position size: $76.65M

Sector Tilt

  • Consumer Discretionary 28.4%
  • Health Care 19.9%
  • Financials 17.9%
  • (classified holdings cover 96% of value)

Quarterly Activity

  • Q2 2026: 2 new, 10 added, 18 reduced, 2 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 19.5%
Financials 17.5%
Technology 16.3%
Energy 4.2%
Utilities 3.4%
Other 6.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 581.64K $182.05M 7.03%
7.03%
Reduce
2 1.29M $150.74M 5.82%
5.82%
Reduce
3 562.56K $129.85M 5.01%
5.01%
Hold
4 3.33M $128.81M 4.97%
4.97%
Add
5 6.47M $124.78M 4.82%
4.82%
Reduce
6 368.29K $121.58M 4.69%
4.69%
Reduce
7 638.81K $119.14M 4.60%
4.60%
Add
8 5.31M $118.48M 4.57%
4.57%
Add
9 576.35K $101.43M 3.92%
3.92%
Add
10 1.23M $97.73M 3.77%
3.77%
Reduce
11 143.09K $94.45M 3.65%
3.65%
Reduce
12 2.37M $92.83M 3.58%
3.58%
Add
13 5.27M $86.95M 3.36%
3.36%
Add
14 18.67M $78.06M 3.01%
3.01%
Reduce
15 575.77K $75.52M 2.92%
2.92%
Reduce
16 654.12K $73.14M 2.82%
2.82%
Reduce
17 2.05M $71.06M 2.74%
2.74%
Reduce
18 758.80K $64.89M 2.50%
2.50%
Add
19 771.65K $62.75M 2.42%
2.42%
Reduce
20 781.70K $59.59M 2.30%
2.30%
Add
21 824.94K $55.72M 2.15%
2.15%
Reduce
22 2.79M $55.44M 2.14%
2.14%
Add
23 1.19M $54.99M 2.12%
2.12%
Reduce
24 2.04M $51.22M 1.98%
1.98%
New
25 176.28K $49.94M 1.93%
1.93%
Reduce
26 680.40K $47.22M 1.82%
1.82%
Reduce
27 178.92K $40.46M 1.56%
1.56%
Add
28 1.28M $36.18M 1.40%
1.40%
Add
29 1.20M $31.38M 1.21%
1.21%
Reduce
30 1.66M $26.96M 1.04%
1.04%
Reduce
31 840.99K $24.14M 0.93%
0.93%
Hold
32 382.13K $22.56M 0.87%
0.87%
Reduce
33 259.16K $17.41M 0.67%
0.67%
New
34 100.11K $14.67M 0.57%
0.57%
Reduce
35 1.88M $11.58M 0.45%
0.45%
Reduce
36 29.38K $9.47M 0.36%
0.36%
Hold
37 125.00K $4.38M 0.17%
0.17%
Hold
38 50.00K $1.22M 0.05%
0.05%
Hold
39 12.50K $1.19M 0.05%
0.05%
Hold
40 1.07K $733.17K 0.03%
0.03%
Add

FAQ

What did Patient Capital Management, LLC buy in 2025-Q4?

In its 2025-Q4 13F filing, Patient Capital Management, LLC reported 40 equity positions worth $2.59B in aggregate; its largest disclosed positions were GOOGL ($182.05M), C ($150.74M), AMZN ($129.85M).

How large is Patient Capital Management, LLC's portfolio?

Patient Capital Management, LLC reported $2.59B of long equity holdings across 40 positions as of 2025-Q4. Top-10 holdings account for 49.2% of reported value.

What is Patient Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/patient-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →